PPARG and infection: The PPARγ agonist rosiglitazone stimulates an M2-like macrophage response, characterized by downregulation of iNOS, while dexamethasone treatment resulted in decreased immune cell migration to the infection site and reduced serum nitrate levels (9, 11).